Direct Rx recalls Moxifloxacin Ophthalmic Solution, 0.5%, 3 mL, Rx Only, Packaged and Distributed By: Direct Rx, LLC 94 Worldwide Drive, D
Recalled January 18, 2023 · FDA recall D-0101-2023 · Direct Rx
Hazard
cGMP deviation: discontinue of stability support for product. · FDA Class II
Units
11 bottles
Sold at
FL
Description
cGMP deviation: discontinue of stability support for product.
Product
Moxifloxacin Ophthalmic Solution, 0.5%, 3 mL, Rx Only, Packaged and Distributed By: Direct Rx, LLC 94 Worldwide Drive, Dawsonville, GA 30534, NDC 72189-0334-05
Manufacturer(s)
Direct Rx
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →